| Patents for A61P 3 - Drugs for disorders of the metabolism (129,789) |
|---|
| 04/17/2002 | EP1196567A2 Human immune response molecules |
| 04/17/2002 | EP1196562A1 Novel genes and their use in the modulation of obesity, diabetes and energy imbalance |
| 04/17/2002 | EP1196444A1 Peptides that lower blood glucose levels |
| 04/17/2002 | EP1196442A1 Vgf polypeptides and methods of treating vgf-related disorders |
| 04/17/2002 | EP1196441A1 Keratinocyte growth factor-2 |
| 04/17/2002 | EP1196438A1 A ligand of the protein "beacon" |
| 04/17/2002 | EP1196430A2 Purification and stabilization of peptide and proteins in pharmaceutical agents |
| 04/17/2002 | EP1196419A1 Potassium channel blocking agents |
| 04/17/2002 | EP1196417A1 1,2,3,4,5,6-HEXAHYDROAZEPINO 4,5-b]INDOLES CONTAINING ARYLSULFONES AT THE 9-POSITION |
| 04/17/2002 | EP1196416A1 Substituted purine derivatives as inhibitors of cell adhesion |
| 04/17/2002 | EP1196414A1 Prodrugs of carbamate inhibitors of impdh |
| 04/17/2002 | EP1196411A1 Bradykinin b1 receptor antagonists |
| 04/17/2002 | EP1196407A1 N-imidazolylmethyl carboxamides as nitric oxide production inhibitors |
| 04/17/2002 | EP1196406A1 Amino ceramide-like compounds and therapeutic methods of use |
| 04/17/2002 | EP1196404A1 Piperazine derivatives as modulators of chemokine receptor activity |
| 04/17/2002 | EP1196390A2 Pyrazole compositions useful as inhibitors of erk |
| 04/17/2002 | EP1196389A1 N-heterocyclic derivatives with neuronal activity |
| 04/17/2002 | EP1196385A1 Beta-amino acid derivatives for the treatment of neurological diseases |
| 04/17/2002 | EP1196195A1 Nasogastric enteral formulations |
| 04/17/2002 | EP1196194A2 COMBINATION OF MTP INHIBITORS AND HMG-CoA REDUCTASE INHIBITORS AND THE USE THEREOF IN MEDICAMENTS |
| 04/17/2002 | EP1196190A1 Use of long-chain n-alkyl derivatives of deoxynojirimycin and a glucocerebrosidase enzyme for the manufacture of a medicament for the treatment of glycolipid storage diseases |
| 04/17/2002 | EP1196189A2 Multiple agent diabetes therapy |
| 04/17/2002 | EP1196188A1 Vgf selective binding agents and methods of treating vgf-related disorders |
| 04/17/2002 | EP1196186A2 Promotion or inhibition of angiogenesis and cardiovascularization by tumor necrosis factor ligand/receptor homologs |
| 04/17/2002 | EP1196181A1 Fat-binding polymers, optionally combined with lipase inhibitors |
| 04/17/2002 | EP1196180A1 Treatment of angiogenesis dependent conditions with dextrin sulphate |
| 04/17/2002 | EP1196172A2 Use of highly selective norepinephrine reuptake inhibitors for the treatment of mental disorders |
| 04/17/2002 | EP1196167A1 Method of reducing neuronal injury or apoptosis |
| 04/17/2002 | EP1196164A2 Methods and compositions for regulating gut motility and food intake |
| 04/17/2002 | EP1196163A2 Methods of treating and/or suppressing weight gain |
| 04/17/2002 | EP1196162A1 Procyanidin oligomers for inhibiting matrix metalloproteinases and medicine having effective composition of same |
| 04/17/2002 | EP1196136A1 Compositions comprising organosiloxane resins for delivering oral care substances |
| 04/17/2002 | EP1196050A1 Compositions, kits, and methods for providing and maintaining energy and mental alertness |
| 04/17/2002 | EP1196047A1 Prophylactic dietary supplement based on milk |
| 04/17/2002 | EP1121145B1 Insulin preparations for pulmonary delivery containing menthol |
| 04/17/2002 | EP1042322B1 Kv2.1 ANTAGONISTS |
| 04/17/2002 | EP1028730B1 Compositions of lipid lowering agents |
| 04/17/2002 | EP0925293A4 Method of producing an extruded nutritional supplement product |
| 04/17/2002 | EP0873129B1 Anion exchange resin-containing tablets |
| 04/17/2002 | EP0831902A4 Muscle trophic factor |
| 04/17/2002 | EP0799035B1 Emulsion suitable for administering a sphingolipid and use thereof |
| 04/17/2002 | EP0783514B1 Sterol compositions from pulping soap |
| 04/17/2002 | EP0707485B1 Anti-cholesterolemic egg, vaccine and method for production, and use |
| 04/17/2002 | EP0676951B1 Use of vitamin d glycosides for the treatment or prevention of osteoporosis |
| 04/17/2002 | EP0607278B1 Method for enhancing gut absorption |
| 04/17/2002 | EP0580606B1 Method for delivering the direct feed microorganism lactobacillus reuteri to avian organisms in ovo |
| 04/17/2002 | CN1345335A Melanocortin receptor ligands |
| 04/17/2002 | CN1345331A Method and composition for angiogenesis inhibition |
| 04/17/2002 | CN1345329A Tumor mecrosis factor receptors 6 alpha and beta |
| 04/17/2002 | CN1345319A Triazole compounds with dopamine-D3-receptor affinity |
| 04/17/2002 | CN1345318A Triazole compounds with dopamine -D3-receptor affinity |
| 04/17/2002 | CN1345314A Amine derivatives as protease inhibitors |
| 04/17/2002 | CN1345312A Dibenzoazulene derivatives for treating thrombosis, osteoporosis arteriosclerosis |
| 04/17/2002 | CN1345311A 1-arenesulfonyl-2-aryl-pyrolidine and piperidine derivatives for treatment of CNS disorders |
| 04/17/2002 | CN1345309A Diaryl derivatives and their use as medicaments |
| 04/17/2002 | CN1345308A Acetylenic alpha-amino acid based sulfonamide hydroxamic acid TACE inhibitors |
| 04/17/2002 | CN1345303A Oxamic acids and derivatives as thyroid receptor ligands |
| 04/17/2002 | CN1345245A Apolipoprotein A-I agonists and their use to treat dyslipidemic disorders |
| 04/17/2002 | CN1345239A Heterocyclic containing biphenyl alpha P2 inhibitors and method |
| 04/17/2002 | CN1345188A Nutritional supplement or pharmaceutical preparation comprising triglycerides with seven-carbon fatty acid |
| 04/17/2002 | CN1344704A Prepn and application of octacosanol |
| 04/17/2002 | CN1344542A Production process and product of instant osteocalcium composition |
| 04/17/2002 | CN1082961C Novel use and novel derivatives of imidazole, method for preparing same, novel intermediates thus obtained, medicinal and applications as medicine and pharmaceutical compositions thereof |
| 04/17/2002 | CN1082815C 吲哚衍生物 Indole derivatives |
| 04/16/2002 | US6372919 (+)-1-(3,4-dichlorophenyl)-3-azabicyclo[3.1.0]hexane, compositions thereof, and uses as an anti-depressant agent |
| 04/16/2002 | US6372790 Metformin, fibrate such as fenofibrate and bezafibrate with excipients |
| 04/16/2002 | US6372776 Crystalline(−)-3R,4R-trans-7-methoxy-2,2-dimethyl-3-phenyl-4-{4-[2-(pyrrolidin-1-yl)ethoxy]phenyl}chromane, hydrogen maleate |
| 04/16/2002 | US6372773 Treatment of inflammation, arthritis with urea or thiourea heterocycles |
| 04/16/2002 | US6372768 2-aminopyridines containing fused ring substituents |
| 04/16/2002 | US6372757 Phenylurea and phenylthio urea derivatives |
| 04/16/2002 | US6372754 Drugs for treatment or prevention of depression, anxiety, pain, inflammation, migraine, emesis or postherpic neuralgia. |
| 04/16/2002 | US6372751 Drugs with benzene and pyrimidine rings |
| 04/16/2002 | US6372743 Certain alkylene diamine-substituted pyrazlo (1,5-a)-1,5-pyrimidines and pyrazolo (1,5-a) 1,3,5-triazines |
| 04/16/2002 | US6372731 Vitamin D derivatives with C-25 substituents, process for their preparation, intermediate products and their use in preparing medicaments |
| 04/16/2002 | US6372728 Formulation for treatment of osteoporosis |
| 04/16/2002 | US6372719 ανβ3 integrin antagonists in combination with chemotherapeutic agents |
| 04/16/2002 | US6372501 Glucose responsive β-cell line |
| 04/16/2002 | US6372473 Tissue plasminogen activator-like protease |
| 04/16/2002 | US6372452 Process for obtaining plant peptones with a high hydrolysis degree and applications thereof |
| 04/16/2002 | US6372431 Mammalian toxicological response markers |
| 04/16/2002 | US6372267 Cocoa solids prepared by heating, pressing, recovering partially defatted cocoa solids which contain cocoa polyphenols including cocoa procyanidins |
| 04/16/2002 | US6372251 Bioavailability |
| 04/16/2002 | CA2088980C Pro-drugs for cck antagonists |
| 04/15/2002 | WO2002030514A2 Insulin receptor activators for the treatment of metabolic disorders in humans resulting from treatment of hiv infection with hiv protease inhibitors |
| 04/15/2002 | CA2421622A1 Insulin receptor activators for the treatment of metabolic disorders in humans resulting from treatment of hiv infection with hiv protease inhibitors |
| 04/11/2002 | WO2002029088A2 Highly expressible genes |
| 04/11/2002 | WO2002029061A2 G-protein coupled receptors |
| 04/11/2002 | WO2002029058A2 Human proteins, polynucleotides encoding them and methods of using the same |
| 04/11/2002 | WO2002029055A2 Carbohydrate-associated proteins |
| 04/11/2002 | WO2002029053A1 Novel g protein-coupled receptor protein and dna thereof |
| 04/11/2002 | WO2002029044A2 Modulation of the transcription of pro-inflammatory gene products |
| 04/11/2002 | WO2002029038A2 Novel proteins and nucleic acids encoding same and antibodies directed against these proteins |
| 04/11/2002 | WO2002029036A2 Lipid metabolism enzymes |
| 04/11/2002 | WO2002028902A2 Nectin polypeptides, polynucleotides, methods of making and use thereof |
| 04/11/2002 | WO2002028880A2 Compounds useful for treating hypertriglyceridemia |
| 04/11/2002 | WO2002028872A1 Glucopyranosyloxybenzylbenzene derivatives and medicinal compositions containing the same |
| 04/11/2002 | WO2002028866A2 Hydroxyesters of 7-desmethylrapamycin |
| 04/11/2002 | WO2002028857A1 Polymorphs of pioglitazone hydrochloride and their use as antidiabetics |
| 04/11/2002 | WO2002028845A1 3-thioxo-[1,2,4]-oxadiazinan-5-one and their use as anti-antherosclerotic agents |
| 04/11/2002 | WO2002028839A1 Benzimidazole and indole derivatives as crf receptor modulators |